Rozlytrek
This information is intended for HCP only. This is a prescription based drug. Please consult your doctor if you need more information.
Rozlytrek (Entrectinib) capsule is a kinase inhibitor indicated for the treatment of adult patients with ROS1-positive metastatic non-small cell lung cancer (NSCLC) as detected by an FDA-approved test.
In case of any adverse events or safety queries, please contact:
If you have a scientific query related to one of Roche's products, please contact:
M-PK-00001707
Solutions
:quality(90)/)